Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge

Clinical trial NCT01107405 · COMPLETED

Trial details

NCT number: NCT01107405
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2010-04-01
Primary completion: 2010-05-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.